This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33361455
rdf:type
wikibase:Item
schema:description
2004年论文 scientific article artikulong pang-agham مقالة علمية мақолаи илмӣ 2004 nî lūn-bûn vědecký článek 2004年论文 vedecký článok научни чланак teaduslik artikkel 2004年论文 научни чланак artículo científico publicado en 2004 სამეცნიერო სტატია επιστημονικό άρθρο мақолаи илмӣ บทความทางวิทยาศาสตร์ 2004年論文 vitskapeleg artikkel bài báo khoa học 2004年論文 מאמר מדעי vetenskaplig artikel 2004年论文 artykuł naukowy научная статья article scientifique (publié 2004) naučni članak artigo científico (publicado na 2004) artikull shkencor artículu científicu espublizáu en 2004 videnskabelig artikel (udgivet 2004) 2004年论文 article scientific artigo científico bilimsel makale سائنسی مضمون articol științific mokslinis straipsnis 2004年论文 2004年論文 مقالهٔ علمی vitenskapelig artikkel 2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված tieteellinen artikkeli 2004年論文 наукова стаття, опублікована у вересні 2004 scienca artikolo article científic tudományos cikk 2004年の論文 научна статия 2004년 논문 artigo científico (publicado na 2004) wissenschaftlicher Artikel articolo scientifico 2004年論文 wetenschappelijk artikel
p:P577
wds:Q33361455-4A5D17BE-19D7-4F90-8DD3-85B59EA9849E
wdt:P577
2004-09-01T00:00:00Z
p:P407
wds:Q33361455-45BF883F-2372-4A16-9701-EB3905F44D97
wdt:P407
wd:Q1860
p:P2860
wds:Q33361455-2D2E9E5E-5CE8-420E-B697-6E12A56284E8 wds:Q33361455-47A3E054-7AB0-4E33-8CED-9CC9F623DC03 wds:Q33361455-0C0F1C2C-4F35-41C6-AF98-8D1199AB668B wds:Q33361455-29D5AEF9-D03F-4C4F-8EBD-44BE98E01D89 wds:Q33361455-6D87C731-68D4-40B4-8CFA-16D8F4454906 wds:Q33361455-67223802-6B70-4569-A848-CD0FEC90F29A wds:Q33361455-50CDC288-3543-468F-8285-924D47DD6B5F wds:Q33361455-546FFC18-4B70-47A8-AA54-1E67AF557BDA wds:Q33361455-EE27EE52-BFF7-4F2C-9A20-BCEE77D639A8 wds:Q33361455-ED21128B-F24A-46B8-AD9B-730EC69333C2 wds:Q33361455-AC06385A-33AE-4C54-BB7A-78967B91E915
wdt:P2860
wd:Q40569180 wd:Q78360878 wd:Q53780184 wd:Q69604954 wd:Q55035623 wd:Q28207989 wd:Q44559233 wd:Q79293567 wd:Q35206364 wd:Q33343994 wd:Q43918508
p:P2093
wds:Q33361455-F9AC098F-3E7D-49CD-AE0E-2589BA1BFAF7 wds:Q33361455-F290E964-C60F-4BC2-B084-57977E56FAC1 wds:Q33361455-9A1A55D4-61F2-4C39-AD4F-98432C749DBE wds:Q33361455-43E0718C-C6D8-4D18-83FD-5D446281CF60
wdt:P2093
Giuseppe Visani Giovanni Sparaventi Luigi Gugliotta Alessandro Bonini
rdfs:label
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
skos:prefLabel
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
schema:name
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
p:P50
wds:Q33361455-68C28FD0-1907-4EE1-AD0B-AB635FDA7A9E wds:Q33361455-7EDF520B-FB46-43A2-9B13-B5C0EB51C2E1 wds:Q33361455-88BA3D30-8373-4F66-8A42-2ED3A02164F3 wds:Q33361455-A99E90D3-978C-4ED4-B0E9-E04D518E4F4C wds:Q33361455-119AB0CD-5D99-4C97-8FC7-C5AA0FF2D548 wds:Q33361455-AD9C2588-B108-4595-BFE7-A2F4109A30D2 wds:Q33361455-B667BE82-6FC7-44C2-91A4-F50A1B806B5E wds:Q33361455-B693A417-567C-4CC9-A535-3FBD628BA897 wds:Q33361455-C7338F1D-0AC2-4A3B-843D-D34CE291CB2E
wdt:P50
wd:Q117194672 wd:Q114516468 wd:Q66370907 wd:Q46389798 wd:Q57214799 wd:Q56909524 wd:Q90151367 wd:Q56452807 wd:Q66370881
p:P1476
wds:Q33361455-5F67F648-F715-47C8-B16B-AB5558C3B082
wdt:P1476
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
p:P304
wds:Q33361455-7EDCD5D2-72BE-4DB4-BE7A-72E5BA2B0CED
wdt:P304
1791-1795
p:P31
wds:Q33361455-6FCDA261-2A07-409B-BCCD-FFAF689F6621
wdt:P31
wd:Q13442814
p:P921
wds:Q33361455-6BAEEAD0-BBA1-4F4A-9282-B95C62069272
wdt:P921
wd:Q264118
p:P698
wds:Q33361455-4C3528D2-E329-4F51-8426-F3A6F941DE21
wdtn:P698
n8:15223637
wdt:P698
15223637
p:P1433
wds:Q33361455-C7911C60-71E0-4C10-BC77-CB01A277BB28
wdt:P1433
wd:Q6534493
p:P433
wds:Q33361455-9104743E-3B30-41E2-A7EF-F43CE7EDF282
p:P478
wds:Q33361455-221D7BA4-146D-4D68-97D6-A3169355EA05
wdt:P433
9
wdt:P478
45
p:P356
wds:Q33361455-B8111122-1370-4E05-9B2E-804336A3E88D
wdtn:P356
n9:1042819042000219485
wdt:P356
10.1080/1042819042000219485